Symptomatic Improvement Within 3 Days With Tofacitinib Induction Therapy in Patients With Ulcerative Colitis: Results From OCTAVE Induction 1 and 2

被引：0
|
作者：
Hanauer, Stephen [1 ]
Panaccione, Remo [2 ]
Danese, Silvio [3 ]
Cheifetz, Adam [4 ,5 ,6 ]
Reinisch, Walter [7 ]
Higgins, Peter D. R. [8 ]
Woodworth, Deborah A. [9 ]
Zhang, Haiying [9 ]
Friedman, Gary S. [9 ]
Lawendy, Nervin [9 ]
Quirk, Daniel [9 ]
Nduaka, Chudy I. [9 ]
Su, Chinyu [9 ]
机构：
[1] Northwestern Univ, Feinberg Sch Med, Evanston, IL USA
[2] Univ Calgary, Dept Med, Calgary, AB, Canada
[3] Humanitas Clin & Res Ctr, Rozzano, Lombardia, Italy
[4] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA
[5] Beth Israel Deaconess Med Ctr, Div Gastroenterol, Boston, MA 02215 USA
[6] Harvard Med Sch, Boston, MA USA
[7] Med Univ Vienna, Hamilton, ON, Canada
[8] Univ Michigan, Ann Arbor, MI 48109 USA
[9] Pfizer Inc, Collegeville, PA USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2017年 / 112卷
关键词：
D O I：
10.14309/00000434-201710001-00609
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
609
引用
收藏
页码：S331 / S331
页数：1
相关论文
共 50 条
  • [41] Tofacitinib as a maintenance therapy in patients with ulcerative colitis stratified by OCTAVE Sustain baseline Mayo endoscopic subscore
    Lee, Scott D.
    Allegretti, Jessica R.
    Steinwurz, Flavio
    Connelly, Susan B.
    Lawendy, Nervin
    Paulissen, Jerome
    Gecse, Krisztina B.
    BMC GASTROENTEROLOGY, 2023, 23 (01)
  • [42] Tofacitinib as a maintenance therapy in patients with ulcerative colitis stratified by OCTAVE Sustain baseline Mayo endoscopic subscore
    Scott D. Lee
    Jessica R. Allegretti
    Flavio Steinwurz
    Susan B. Connelly
    Nervin Lawendy
    Jerome Paulissen
    Krisztina B. Gecse
    BMC Gastroenterology, 23
  • [43] Improvement in Physician's Global Assessment Within 2 Weeks in Patients With Ulcerative Colitis Treated With Tofacitinib
    Chiorean, Michael
    Rubin, David T.
    Lowenberg, Mark
    Gisbert, Javier P.
    Tsilkos, Konstantinos
    Quirk, Daniel
    Salese, Leonardo
    Zhang, Haiying
    Woodworth, Deborah A.
    Su, Chinyu
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S414 - S414
  • [44] Disease Activity and Health-related Quality of Life Relationships with Work Productivity in Patients with Ulcerative Colitis in OCTAVE Induction 1 and 2 and OCTAVE Sustain
    Targownik, Laura
    Dubinsky, Marla C.
    Steinwurz, Flavio
    Bushmakin, Andrew G.
    Cappelleri, Joseph C.
    Tai, Elaine
    Gardiner, Sean
    Hur, Peter
    Panes, Julian
    JOURNAL OF CROHNS & COLITIS, 2022, : 513 - 523
  • [45] THE EFFECT OF TOFACITINIB ON SERUM LIPIDS AND CARDIOVASCULAR SAFETY IN PATIENTS WITH ULCERATIVE COLITIS - RESULTS FROM THE TOFACITINIB ULCERATIVE COLITIS CLINICAL PROGRAM
    Sands, Bruce E.
    Taub, Pam R.
    Feagan, Brian G.
    Armuzzi, Alessandro
    Friedman, Gary S.
    Moscariello, Michele
    Lawendy, Nervin
    Pedersen, Ronald D.
    Chan, Gary
    Nduaka, Chudy I.
    Quirk, Daniel
    Salese, Leonardo
    Su, Chinyu
    GASTROENTEROLOGY, 2018, 154 (06) : S380 - S380
  • [46] The effect of tofacitinib on serum lipids and cardiovascular safety in patients with ulcerative colitis: results from the tofacitinib ulcerative colitis clinical programme
    Sands, B. E.
    Taub, P. R.
    Feagan, B. G.
    Armuzzi, A.
    Friedman, G. S.
    Moscariello, M.
    Lawendy, N.
    Pedersen, R. D.
    Chan, G.
    Nduaka, C. I.
    Quirk, D.
    Salese, L.
    Su, C.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S23 - S23
  • [47] Long-term efficacy of tofacitinib in patients who received extended induction therapy: results of the OCTAVE open study for tofacitinib delayed responders
    Rubin, D. T.
    Dubinsky, M. C.
    Lukas, M.
    Quirk, D.
    Nduaka, C. I.
    Maller, E.
    Lawendy, N.
    Kayhan, C.
    Fan, H.
    Woodworth, D. A.
    Chan, G.
    Su, C.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S51 - S52
  • [48] LONG-TERM EFFICACY OF TOFACITINIB IN PATIENTS WHO RECEIVED EXTENDED INDUCTION THERAPY: RESULTS OF THE OCTAVE OPEN STUDY FOR TOFACITINIB DELAYED RESPONDERS
    Rubin, David T.
    Dubinsky, Marla
    Lukas, Milan
    Quirk, Daniel
    Nduaka, Chudy I.
    Maller, Eric S.
    Lawendy, Nervin
    Kayhan, Cem
    Fan, Haiyun
    Woodworth, Deborah A.
    Chan, Gary
    Su, Chinyu
    GASTROENTEROLOGY, 2019, 156 (06) : S1102 - S1102
  • [49] Tofacitinib Plasma Concentration Monitoring Is Not Needed for Optimization of Induction Therapy in Moderate to Severe Ulcerative Colitis: Results of Pooled Exposure-Response Analyses of Phase 3 Induction Studies
    Mukherjee, Arnab
    Tsuchiwata, Shinichi
    Deng, Chenhui
    Vong, Camille
    Xie, Rujia
    Martin, Steven W.
    Yu, Dahong
    Woodworth, Deborah A.
    Niezychowski, Wojciech
    Su, Chinyu
    GASTROENTEROLOGY, 2016, 150 (04) : S774 - S774
  • [50] Guselkumab induction therapy results in molecular resolution of inflammation in moderately to severely active Ulcerative Colitis: results from the Phase 3 QUASAR induction study
    Sridhar, S.
    Hart, A.
    Venkat, S.
    Huang, K. H. G.
    Yarandi, S.
    Germinaro, M.
    Vetter, M.
    Rubin, D. T.
    Dignass, A.
    Cua, D.
    Freeman, T.
    Waterworth, D.
    Mcrae, B.
    Verstockt, B.
    Branigan, P.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i422 - i422
12345